Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-controlled Thyrax dose and quality of life in hypothyroidism
NL-OMON36807Not yet recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levothyroxine sodium and Placebo-COD Research Private Ltd in primary hypothyroidism (PH) (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoints: Quality of life by SF/RAND-36, Hypothyroidism symptom and complaint score and 2 more. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
levothyroxine sodiumPlacebo-COD Research Private Ltd
03
Conditions
primary hypothyroidism (PH)
Beyond the preview
Go deeper on NL-OMON36807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36807.